- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
有加速下跌的趋势。
- 长期趋势：
已有2家主力机构披露2025-06-30报告期持股数据，持仓量总计1.25亿股，占流通A股14.18%
- 波段诊断：
-
技术面诊股
诊断结果：1.8技术面打败了0%的股票
技术面评分前10的股票
近期的平均成本为6.77元。空头行情中，并且有加速下跌的趋势。
平均成本
近期的平均成本为6.77元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"6.77","date":1770623549,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，明显跑输行业平均水平。
[{"date":"2026.02.10","stock":"-1.62","trade":"0.52","ind":"0.02"},{"date":"2026.02.09","stock":"-1.17","trade":"0.67","ind":"2.17"},{"date":"2026.02.06","stock":"-2.28","trade":"0.56","ind":"-0.33"},{"date":"2026.02.05","stock":"2.18","trade":"0.23","ind":"-1.44"},{"date":"2026.02.04","stock":"-2.14","trade":"0.76","ind":"2.40"},{"date":"2026.02.02","stock":"0.72","trade":"-2.55","ind":"-2.69"},{"date":"2026.01.30","stock":"-3.46","trade":"-0.63","ind":"-0.66"},{"date":"2026.01.29","stock":"-3.21","trade":"-0.82","ind":"-0.30"},{"date":"2026.01.28","stock":"-2.61","trade":"-1.60","ind":"0.09"},{"date":"2026.01.27","stock":"-0.13","trade":"-1.34","ind":"0.09"},{"date":"2026.01.26","stock":"0.13","trade":"0.66","ind":"-0.85"},{"date":"2026.01.23","stock":"0.13","trade":"1.43","ind":"0.79"},{"date":"2026.01.22","stock":"-0.78","trade":"-0.07","ind":"0.50"},{"date":"2026.01.21","stock":"0.13","trade":"0.37","ind":"0.70"},{"date":"2026.01.20","stock":"-2.16","trade":"-0.41","ind":"-0.97"},{"date":"2026.01.19","stock":"4.23","trade":"0.41","ind":"0.09"},{"date":"2026.01.16","stock":"-0.40","trade":"-0.81","ind":"-0.18"},{"date":"2026.01.15","stock":"-2.69","trade":"-1.14","ind":"0.41"},{"date":"2026.01.14","stock":"-4.65","trade":"-0.56","ind":"0.56"},{"date":"2026.01.13","stock":"-0.12","trade":"1.21","ind":"-1.37"},{"date":"2026.01.12","stock":"5.00","trade":null,"ind":"1.75"}]
*ST景峰,深证成指,化学制药指数
压力支撑
该股压力位为6.73元，支撑位为6.61元。
[{"text":"\u538b\u529b\u4f4d","value":"6.73","date":1770652800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"6.61","date":1770652800,"color":"0x0b52a1"}]
多空趋势
空头行情中，并且有加速下跌的趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.6资金面打败了24%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流入状态，投资者可考虑关注该行业的个股。
更新时间：02月10日 16:47
| 机构今日流向(万元) | 998.19 | 机构5日流向(万元) | 1555.18 |
| 机构10日流向(万元) | -6442.45 | 机构20日流向(万元) | -25805.89 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量不变，其中基金数没有增加，主力数没有增加，暂未发现中长期投资价值。
截止2025-06-30，共2家主力机构（一般法人2家），持仓量总计12476.41万股，占流通A股14.18%
其中，基金持仓与2024-12-31相比：
增仓：0家 ，增持 0万股
减仓：0家 ，减持 0万股
新出现在主力名单中：0家 ，持有万股
从主力名单中消失：0家 ，原持有万股
其中，基金持仓与2024-12-31相比：
增仓：0家 ，增持 0万股
减仓：0家 ，减持 0万股
新出现在主力名单中：0家 ，持有万股
从主力名单中消失：0家 ，原持有万股
消息面诊股
诊断结果：5.4消息面打败了27%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- *ST景峰：重整投资款20.61亿元已到账
2026-02-06 - 中伦助力景峰医药重整计划获得法院裁定批准
2026-02-06 - 景峰医药重整计划获批
2026-02-04 - *ST景峰：重整计划将每10股转增10股
2026-02-03 - *ST景峰：重整计划获得法院裁定批准
2026-02-03 - *ST景峰：预计2025年全年亏损9000.00万
2026-01-29 - *ST景峰：预计2025年净利润为负值
2026-01-29 - 关停率逼近20%？1247家民营医院消失，药械巨头
2026-01-20 - 一只创新药概念湘股不到两年股价上涨10倍
2026-01-19 - 石药二代蔡磊接棒后“首战”：重整景峰医药
2026-01-16
消息列表
| 利空 | 业绩预告 | 业绩预亏 | 2026-01-30 |
| 一般消息 | 重大事项 | 公司股东股份冻结 | 2026-01-24 |
| 利好 | 分红转增 | 10转10股 | 2026-01-13 |
| 一般消息 | 重大事项 | 关联交易 | 2025-12-31 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-12-30 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-12-13 |
| 一般消息 | 重大事项 | 关联交易 | 2025-12-13 |
| 一般消息 | 高管变动 | 因个人原因 | 2025-10-27 |
| 一般消息 | 重大事项 | 公司股东股份解冻 | 2025-10-24 |
| 利空 | 上市变动 | 特别处理*ST | 2025-10-23 |
| 一般消息 | 重大事项 | 关联交易 | 2025-10-09 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-25 |
| 一般消息 | 重大事项 | 公司股东股份冻结 | 2025-07-22 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 利好 | 上市变动 | 公司摘* | 2025-06-16 |
| 一般消息 | 重大事项 | 关联交易 | 2025-05-30 |
| 一般消息 | 高管变动 | 因工作分工调整 | 2025-05-28 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-04-29 |
| 一般消息 | 高管变动 | 因达到法定退休年龄 | 2025-04-24 |
| 一般消息 | 资产重组 | 公司股权转让 | 2025-02-15 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 2条 | 0条 | 2条 |
行业面诊股
诊断结果：6.0行业面打败了74%的股票
化学制药行业最新资金流向
近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2026.02.10","price":"0.02","value":"0.52"},{"date":"2026.02.09","price":"2.17","value":"0.67"},{"date":"2026.02.06","price":"-0.33","value":"0.56"},{"date":"2026.02.05","price":"-1.44","value":"0.23"},{"date":"2026.02.04","price":"2.40","value":"0.76"},{"date":"2026.02.02","price":"-2.69","value":"1.56"},{"date":"2026.01.30","price":"-0.66","value":"-2.55"},{"date":"2026.01.29","price":"-0.30","value":"-0.63"},{"date":"2026.01.28","price":"0.09","value":"-0.82"},{"date":"2026.01.27","price":"0.09","value":"-1.60"},{"date":"2026.01.26","price":"-0.85","value":"-1.34"},{"date":"2026.01.23","price":"0.79","value":"0.66"},{"date":"2026.01.22","price":"0.50","value":"1.43"},{"date":"2026.01.21","price":"0.70","value":"-0.07"},{"date":"2026.01.20","price":"-0.97","value":"0.37"},{"date":"2026.01.19","price":"0.09","value":"-0.41"},{"date":"2026.01.16","price":"-0.18","value":"0.41"},{"date":"2026.01.15","price":"0.41","value":"-0.81"},{"date":"2026.01.14","price":"0.56","value":"-1.14"},{"date":"2026.01.13","price":"-1.37","value":"-0.56"},{"date":"2026.01.12","price":"1.75","value":"1.21"}]
深证成指,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 广生堂 | 49.82% | 25.42% | 5.5分 |
| 2 | 润都股份 | 26.00% | 2.48% | 5.8分 |
| 3 | 新和成 | 18.10% | 14.14% | 6.6分 |
| 4 | 海翔药业 | 17.70% | 21.10% | 5.8分 |
| 5 | 山河药辅 | 14.47% | 5.02% | 4.7分 |
| 6 | 多瑞医药 | 14.29% | 1.71% | 4.3分 |
| 8 | 浙江医药 | 13.74% | 9.65% | 6.7分 |
| 10 | 科源制药 | 11.91% | 4.19% | 5.7分 |
| 12 | 易明医药 | 11.11% | -0.86% | 6.8分 |
| 14 | 同和药业 | 10.61% | 7.05% | 6.5分 |
| 16 | 东亚药业 | 8.76% | 1.87% | 4.0分 |
| 18 | 誉衡药业 | 7.41% | 1.46% | 6.3分 |
| 20 | 北陆药业 | 5.70% | 5.38% | 6.8分 |
| 22 | 健友股份 | 4.69% | 3.83% | 5.9分 |
| 24 | 威尔药业 | 4.30% | 1.77% | 5.9分 |
| 26 | 汉商集团 | 4.25% | 6.69% | 4.6分 |
| 28 | 尔康制药 | 3.77% | 5.48% | 4.0分 |
| 30 | 神奇制药 | 3.50% | 3.83% | 6.0分 |
| 32 | 新天地 | 3.22% | 2.72% | 5.3分 |
| 34 | 罗欣药业 | 3.17% | 10.17% | 6.5分 |
| 36 | 丰原药业 | 2.60% | 2.29% | 5.9分 |
| 38 | 金城医药 | 2.52% | 4.95% | 4.7分 |
| 40 | 首药控股 | 2.27% | 13.53% | 5.1分 |
| 42 | 富士莱 | 1.92% | 4.76% | 5.0分 |
| 44 | ST人福 | 1.50% | 3.05% | 6.0分 |
| 46 | 联环药业 | 1.20% | 4.71% | 6.2分 |
| 48 | 美诺华 | 1.04% | 3.48% | 4.7分 |
| 50 | 小方制药 | 0.87% | 0.30% | 4.2分 |
| 52 | ST复华 | 0.56% | 2.50% | 3.9分 |
| 54 | 华润双鹤 | 0.27% | 0.81% | 5.6分 |
| 56 | 中关村 | 0.19% | 2.33% | 6.1分 |
| 58 | 力生制药 | 0.14% | 1.89% | 5.0分 |
| 60 | - | -0.16% | 2.33% | 分 |
| 62 | 复旦张江 | -0.22% | 3.74% | 4.4分 |
| 64 | 溢多利 | -0.43% | 3.43% | 3.9分 |
| 66 | 能特科技 | -0.57% | 5.14% | 5.1分 |
| 68 | *ST三圣 | -0.91% | 8.50% | 5.2分 |
| 70 | 哈药股份 | -1.12% | 1.15% | 5.2分 |
| 72 | 河化股份 | -1.62% | 1.96% | 6.2分 |
| 74 | 天宇股份 | -1.96% | 8.81% | 5.9分 |
| 76 | 南新制药 | -2.13% | 5.17% | 4.8分 |
| 78 | - | -2.14% | 1.76% | 分 |
| 80 | 九典制药 | -2.27% | 1.44% | 4.3分 |
| 82 | 信立泰 | -2.40% | 14.75% | 6.7分 |
| 84 | 莱美药业 | -2.65% | 3.42% | 4.1分 |
| 86 | 福安药业 | -2.83% | 0.68% | 3.8分 |
| 88 | 丽珠集团 | -3.08% | 1.69% | 5.8分 |
| 90 | 纳微科技 | -3.65% | -2.72% | 4.9分 |
| 92 | 复星医药 | -3.90% | 2.81% | 5.5分 |
| 94 | - | -4.04% | 2.50% | 分 |
| 96 | - | -4.16% | -0.17% | 分 |
| 98 | 拓新药业 | -4.25% | 0.38% | 3.0分 |
| 100 | 千红制药 | -4.34% | 2.98% | 4.8分 |
| 102 | 奥翔药业 | -4.45% | 1.02% | 3.9分 |
| 104 | 亿帆医药 | -4.66% | 2.42% | 5.2分 |
| 106 | 广济药业 | -4.71% | 5.34% | 6.3分 |
| 108 | 永安药业 | -4.76% | 2.32% | 4.0分 |
| 110 | 亚太药业 | -4.78% | 0.42% | 4.9分 |
| 112 | 科伦药业 | -5.57% | 5.39% | 6.0分 |
| 114 | 贝达药业 | -6.33% | 3.04% | 5.6分 |
| 116 | 微芯生物 | -6.78% | 1.96% | 4.2分 |
| 118 | 京新药业 | -7.00% | 2.16% | 5.2分 |
| 120 | 川宁生物 | -7.39% | 2.29% | 5.2分 |
| 122 | 百济神州 | -7.97% | 4.62% | 5.5分 |
| 124 | 哈三联 | -8.27% | 4.02% | 4.2分 |
| 126 | 艾力斯 | -8.50% | -1.00% | 4.9分 |
| 128 | 一品红 | -8.81% | 3.67% | 4.9分 |
| 130 | 恒瑞医药 | -9.49% | 1.62% | 6.0分 |
| 132 | - | -10.52% | -0.94% | 分 |
| 134 | ST诺泰 | -11.32% | 1.32% | 4.4分 |
| 136 | 海创药业 | -11.85% | 0.90% | 4.1分 |
| 138 | 博瑞医药 | -12.55% | 1.95% | 3.6分 |
| 140 | 必贝特 | -12.71% | 6.74% | 4.1分 |
| 142 | 奥锐特 | -14.27% | -0.95% | 4.0分 |
| 144 | 奥赛康 | -15.00% | 1.00% | 5.1分 |
| 146 | 昂利康 | -15.24% | 2.99% | 5.2分 |
| 148 | 双鹭药业 | -15.88% | 3.28% | 4.0分 |
| 150 | 常山药业 | -17.29% | -1.61% | 3.9分 |
| 152 | 迪哲医药 | -19.70% | 0.70% | 4.2分 |
| 154 | 海辰药业 | -20.67% | 0.25% | 4.0分 |
| 156 | 益方生物 | -28.52% | 2.09% | 3.4分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信建投 | 2012-09-10 | 增持 | 增持 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 申银万国 | 2012-09-10 | 增持 | 增持 |
| 国都证券 | 2012-09-10 | 增持 | - |
| 长江证券 | 2012-09-09 | 增持 | 增持 |
更多>>行业资讯
- 2012-09-13科达机电稳步上涨 3大业务或刺激业绩大增
- 2012-09-13二重重装职工董事辞职及增补职工董事
- 2012-09-13凤凰光学修订<公司章程>部分条款
- 2012-09-13南通锻压：使用募集资金对南通锻压设备（天津）有限公
- 2012-09-13华中数控：重大资产重组进展
- 2012-09-13华西能源：获得中国证监会核准公开发行公司债券批复
- 2012-09-13海源机械：持股5%以上股东减持股份
- 2012-09-13中原内配：通过德国DaimlerAG（戴姆勒有限公
- 2012-09-13杰瑞股份：重大事项停牌
- 2012-09-13航天科技：股票交易异常波动
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 147/217 ， 39/217。
[{"date":"2025-09-30","value":"-74.84","vol":"1.51"},{"date":"2025-06-30","value":"-49.70","vol":"1.23"},{"date":"2025-03-31","value":"-15.69","vol":"-0.14"},{"date":"2024-12-31","value":"2684.86","vol":"19.62"},{"date":"2024-09-30","value":"","vol":"4.62"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
-74.84 | -49.70 | -15.69 | 2684.86 | - |
| 行业(%) | 1.51 | 1.23 | -0.14 | 19.62 | 4.62 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"64.64","vol":"49.36"},{"date":"2025-06-30","value":"65.33","vol":"49.33"},{"date":"2025-03-31","value":"66.62","vol":"49.14"},{"date":"2024-12-31","value":"62.80","vol":"50.78"},{"date":"2024-09-30","value":"59.93","vol":"50.61"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
64.64 | 65.33 | 66.62 | 62.80 | 59.93 |
| 行业(%) | 49.36 | 49.33 | 49.14 | 50.78 | 50.61 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 98/217 ， 57/217。
[{"date":"2025-09-30","value":"-7.75","vol":"142.98"},{"date":"2025-06-30","value":"-9.47","vol":"79.25"},{"date":"2025-03-31","value":"-0.46","vol":"-0.67"},{"date":"2024-12-31","value":"-36.67","vol":"18.07"},{"date":"2024-09-30","value":"-46.79","vol":"45.94"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-7.75 | -9.47 | -0.46 | -36.67 | -46.79 |
| 行业(%) | 142.98 | 79.25 | -0.67 | 18.07 | 45.94 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"8.71","vol":"-3.26"},{"date":"2025-06-30","value":"1.47","vol":"58.57"},{"date":"2025-03-31","value":"-960.04","vol":"-11.22"},{"date":"2024-12-31","value":"164.51","vol":"-22.02"},{"date":"2024-09-30","value":"-37.65","vol":"-34.66"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
8.71 | 1.47 | -960.04 | 164.51 | -37.65 |
| 行业(%) | -3.26 | 58.57 | -11.22 | -22.02 | -34.66 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 68/217 ， 54/217。
[{"date":"2025-09-30","value":"0.30","vol":"0.31"},{"date":"2025-06-30","value":"0.20","vol":"0.21"},{"date":"2025-03-31","value":"0.11","vol":"0.10"},{"date":"2024-12-31","value":"0.42","vol":"0.43"},{"date":"2024-09-30","value":"0.28","vol":"0.33"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.30 | 0.20 | 0.11 | 0.42 | 0.28 |
| 行业(次) | 0.31 | 0.21 | 0.10 | 0.43 | 0.33 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"2.01","vol":"1.94"},{"date":"2025-06-30","value":"1.39","vol":"1.30"},{"date":"2025-03-31","value":"0.73","vol":"0.66"},{"date":"2024-12-31","value":"2.85","vol":"3.19"},{"date":"2024-09-30","value":"2.00","vol":"2.12"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
2.01 | 1.39 | 0.73 | 2.85 | 2.00 |
| 行业(次) | 1.94 | 1.30 | 0.66 | 3.19 | 2.12 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"36.07","vol":"4.43"},{"date":"2025-06-30","value":"-15.76","vol":"2.74"},{"date":"2025-03-31","value":"11.44","vol":"-26.98"},{"date":"2024-12-31","value":"-23.45","vol":"-373.99"},{"date":"2024-09-30","value":"7.03","vol":"-9.47"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 36.07 | -15.76 | 11.44 | -23.45 | 7.03 |
| 行业 | 4.43 | 2.74 | -26.98 | -373.99 | -9.47 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.04","vol":"1.73"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.05","vol":"2.00"},{"date":"2024-09-30","value":"","vol":"0.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.04 | - | 0.05 | - |
| 行业 | 0.00 | 1.73 | 0.00 | 2.00 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 100/217 ， 75/217。
[{"date":"2025-09-30","value":"0.39","vol":"3.50"},{"date":"2025-06-30","value":"0.19","vol":"3.69"},{"date":"2025-03-31","value":"0.24","vol":"3.61"},{"date":"2024-12-31","value":"0.25","vol":"3.36"},{"date":"2024-09-30","value":"0.20","vol":"3.67"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
0.39 | 0.19 | 0.24 | 0.25 | 0.20 |
| 行业 | 3.50 | 3.69 | 3.61 | 3.36 | 3.67 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.30","vol":"2.75"},{"date":"2025-06-30","value":"0.12","vol":"2.90"},{"date":"2025-03-31","value":"0.17","vol":"2.83"},{"date":"2024-12-31","value":"0.19","vol":"2.65"},{"date":"2024-09-30","value":"0.12","vol":"2.93"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
0.30 | 0.12 | 0.17 | 0.19 | 0.12 |
| 行业 | 2.75 | 2.90 | 2.83 | 2.65 | 2.93 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 147/217 ， 1/217。
[{"date":"2025-09-30","value":"104.30","vol":"33.63"},{"date":"2025-06-30","value":"105.23","vol":"33.66"},{"date":"2025-03-31","value":"102.85","vol":"33.90"},{"date":"2024-12-31","value":"101.61","vol":"34.07"},{"date":"2024-09-30","value":"121.86","vol":"32.87"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
104.30 | 105.23 | 102.85 | 101.61 | 121.86 |
| 行业(%) | 33.63 | 33.66 | 33.90 | 34.07 | 32.87 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"24.55","vol":"0.94"},{"date":"2025-06-30","value":"19.32","vol":"0.88"},{"date":"2025-03-31","value":"13.58","vol":"1.47"},{"date":"2024-12-31","value":"11.68","vol":"0.84"},{"date":"2024-09-30","value":"","vol":"0.73"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
24.55 | 19.32 | 13.58 | 11.68 | - |
| 行业(%) | 0.94 | 0.88 | 1.47 | 0.84 | 0.73 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2025年的收益，请投资者后续关注。
[{"date":"2021","yellowRectValue":"-1.53","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"-1.23","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-2.36","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"1.52","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]